Edition:
India

Cumberland Pharmaceuticals Inc (CPIX.OQ)

CPIX.OQ on NASDAQ Stock Exchange Global Select Market

4.85USD
9:00pm IST
Change (% chg)

$0.10 (+2.11%)
Prev Close
$4.75
Open
$4.88
Day's High
$4.88
Day's Low
$4.85
Volume
340
Avg. Vol
6,365
52-wk High
$6.99
52-wk Low
$4.52

Latest Key Developments (Source: Significant Developments)

Cumberland Pharmaceuticals Announces FDA Orphan Drug Grant Award For New Phase II Clinical Program
Tuesday, 24 Sep 2019 

Sept 24 (Reuters) - Cumberland Pharmaceuticals Inc ::CUMBERLAND PHARMACEUTICALS ANNOUNCES FDA ORPHAN DRUG GRANT AWARD FOR NEW PHASE II CLINICAL PROGRAM.CUMBERLAND PHARMACEUTICALS INC - HAS BEEN AWARDED JUST OVER $1 MILLION IN FUNDING FROM FDA THROUGH THEIR ORPHAN DRUG GRANT PROGRAM.  Full Article

Cumberland Pharmaceuticals Reports Fourth Quarter Results
Wednesday, 27 Feb 2019 

Feb 26 (Reuters) - Cumberland Pharmaceuticals Inc ::CUMBERLAND PHARMACEUTICALS REPORTS FOURTH QUARTER REVENUE GROWTH OF 16%.Q4 ADJUSTED EARNINGS PER SHARE $0.10.Q4 REVENUE ROSE 16 PERCENT TO $13.5 MILLION.QTRLY LOSS PER SHARE $0.14.  Full Article

Cumberland Pharmaceuticals - Got Notification From FDA Setting PDUFA Action Date
Friday, 25 Jan 2019 

Jan 24 (Reuters) - Cumberland Pharmaceuticals Inc ::CUMBERLAND PHARMA - GOT NOTIFICATION FROM FDA SETTING SEPT 2019 AS PDUFA ACTION DATE FOR APPROVAL DECISION REGARDING NDA FOR METHOTREXATE PRODUCT LINE.CUMBERLAND PHARMACEUTICALS - REMITTED PAYMENT OF $1.3 MILLION TO FDA FOR PDUFA APPLICATION FEE ASSOCIATED WITH METHOTREXATE PRODUCT LINE NDA.  Full Article

Cumberland Pharmaceuticals Says received CRL From FDA Needed For Approval Of Caldolor Injection
Saturday, 4 Aug 2018 

Aug 3 (Reuters) - Cumberland Pharmaceuticals Inc ::CUMBERLAND PHARMACEUTICALS-ON AUGUST 2, RECEIVED CRL FROM FDA OUTLINING ADDITIONAL INFORMATION NEEDED FOR APPLICATION'S APPROVAL OF CALDOLOR INJECTION.CUMBERLAND PHARMACEUTICALS - COMPLETE RESPONSE REQUESTS FROM FDA ARE FOR ADDITIONAL QUALITY & NONCLINICAL DATA.  Full Article